aprepitant

Generic: aprepitant

Labeler: torrent pharmaceuticals limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name aprepitant
Generic Name aprepitant
Labeler torrent pharmaceuticals limited
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

aprepitant 80 mg/1

Manufacturer
Torrent Pharmaceuticals Limited

Identifiers & Regulatory

Product NDC 13668-592
Product ID 13668-592_13e87c01-b873-4d28-a5b3-3a51e49d4dd9
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211835
Listing Expiration 2026-12-31
Marketing Start 2020-10-21

Pharmacologic Class

Established (EPC)
substance p/neurokinin-1 receptor antagonist [epc]
Mechanism of Action
neurokinin 1 antagonists [moa] cytochrome p450 3a4 inhibitors [moa] cytochrome p450 2c9 inducers [moa] cytochrome p450 3a4 inducers [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 13668592
Hyphenated Format 13668-592

Supplemental Identifiers

RxCUI
403810 403811 644088 754508
UNII
1NF15YR6UY
NUI
N0000010262 N0000175786 N0000182141 N0000185507 N0000185506

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name aprepitant (source: ndc)
Generic Name aprepitant (source: ndc)
Application Number ANDA211835 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 80 mg/1
source: ndc
Packaging
  • 2 BLISTER PACK in 1 CARTON (13668-592-84) / 1 CAPSULE in 1 BLISTER PACK (13668-592-85)
  • 3 BLISTER PACK in 1 CARTON (13668-592-86) / 2 CAPSULE in 1 BLISTER PACK (13668-592-83)
source: ndc

Packages (2)

13668-592-84 2 BLISTER PACK in 1 CARTON (13668-592-84) / 1 CAPSULE in 1 BLISTER PACK (13668-592-85) 13668-592-86 3 BLISTER PACK in 1 CARTON (13668-592-86) / 2 CAPSULE in 1 BLISTER PACK (13668-592-83)

Ingredients (1)

aprepitant (80 mg/1)

Linked Drug Pages (1)

APREPITANT ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "13e87c01-b873-4d28-a5b3-3a51e49d4dd9", "openfda": {"nui": ["N0000010262", "N0000175786", "N0000182141", "N0000185507", "N0000185506"], "unii": ["1NF15YR6UY"], "rxcui": ["403810", "403811", "644088", "754508"], "spl_set_id": ["af9b6086-4bf2-472c-8740-4134eaaebace"], "pharm_class_epc": ["Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Neurokinin 1 Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]"], "manufacturer_name": ["Torrent Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 BLISTER PACK in 1 CARTON (13668-592-84)  / 1 CAPSULE in 1 BLISTER PACK (13668-592-85)", "package_ndc": "13668-592-84", "marketing_start_date": "20201021"}, {"sample": false, "description": "3 BLISTER PACK in 1 CARTON (13668-592-86)  / 2 CAPSULE in 1 BLISTER PACK (13668-592-83)", "package_ndc": "13668-592-86", "marketing_start_date": "20201021"}], "brand_name": "APREPITANT", "product_id": "13668-592_13e87c01-b873-4d28-a5b3-3a51e49d4dd9", "dosage_form": "CAPSULE", "pharm_class": ["Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Neurokinin 1 Antagonists [MoA]", "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "product_ndc": "13668-592", "generic_name": "APREPITANT", "labeler_name": "Torrent Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "APREPITANT", "active_ingredients": [{"name": "APREPITANT", "strength": "80 mg/1"}], "application_number": "ANDA211835", "marketing_category": "ANDA", "marketing_start_date": "20201021", "listing_expiration_date": "20261231"}